Your browser doesn't support javascript.
loading
Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse.
Cadot, Sarah; Valle, Carine; Tosolini, Marie; Pont, Frederic; Largeaud, Laetitia; Laurent, Camille; Fournie, Jean Jacques; Ysebaert, Loic; Quillet-Mary, Anne.
Afiliação
  • Cadot S; Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France.
  • Valle C; Université Toulouse III Paul-Sabatier, Toulouse, France.
  • Tosolini M; ERL 5294 CNRS, Toulouse, France.
  • Pont F; Laboratoire d'Excellence Toulouse Cancer, TOUCAN, Toulouse, France.
  • Largeaud L; Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France.
  • Laurent C; Université Toulouse III Paul-Sabatier, Toulouse, France.
  • Fournie JJ; ERL 5294 CNRS, Toulouse, France.
  • Ysebaert L; Laboratoire d'Excellence Toulouse Cancer, TOUCAN, Toulouse, France.
  • Quillet-Mary A; Centre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France.
Biomark Res ; 8(1): 72, 2020 Dec 09.
Article em En | MEDLINE | ID: mdl-33298182
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Biomark Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Biomark Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França